Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVaxxinity, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q3 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
Vaxxinity, Inc. Earnings Date And Information
Vaxxinity, Inc. last posted its earnings results on Wednesday, March 27th, 2024. The company reported $-0.09 earnings per share for the quarter, topping analysts' consensus estimates of $-0.13 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Vaxxinity, Inc. has generated $0 earnings per share over the last year ($-0.45 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Vaxxinity, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 23rd, 2024 based on prior year's report dates.
Vaxxinity, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/29/2024 | Q4 2023 | -$0.09 | $0 | $0 | ||
| 11/08/2023 | Q3 2023 | -$0.14 | -$0.10 | 0.04 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.16 | -$0.11 | 0.05 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.16 | -$0.15 | 0.01 | $0 | |
| 03/27/2023 | Q4 2022 | -$0.16 | -$0.16 | 0 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.16 | -$0.15 | 0.01 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.38 | -$0.14 | 0.24 | $0 | |
| 05/09/2022 | Q1 2022 | -$0.34 | -$0.15 | 0.19 | $0 | |
| 03/24/2022 | Q4 2021 | -$0.35 | -$0.38 | -0.03 | $-1,000 | |
| 12/23/2021 | Q3 2021 | -$0.13 | -$0.24 | -0.11 | $50,000 | |
| 06/29/2021 | Q2 2021 | -$0.22 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.26 | $17,000 | |||
| 12/31/2020 | Q4 2020 | -$0.10 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.13 | $117,000 | |||
| 06/29/2020 | Q2 2020 | -$0.06 | $440,000 | |||
| 03/30/2020 | Q1 2020 | -$0.11 | $0 |
Vaxxinity, Inc. Earnings: FAQ's
When is Vaxxinity, Inc.'s earnings date?
Vaxxinity, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 23rd, 2024 based off last year's report dates.
Did Vaxxinity, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Vaxxinity, Inc. (:VAXX) reported $-0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.04.
How can I listen to Vaxxinity, Inc.'s earnings conference
call?
The conference call for Vaxxinity, Inc.'s latest earnings report can be listened to online.
How can I read Vaxxinity, Inc.'s conference call transcript?
The conference call transcript for Vaxxinity, Inc.'s latest earnings report can be read online.
How much profit does Vaxxinity, Inc. generate each year?
Vaxxinity, Inc. (:VAXX) has a recorded net income of $0. Vaxxinity, Inc. has generated $-0.45 earnings per share over the last four quarters.
What is Vaxxinity, Inc.'s price-to-earnings ratio?
Vaxxinity, Inc. (:VAXX) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.